We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PG&E
PCG
$37.9B
| $53.4M | 0.13% |
804,202
-169,501
| -17% | -$11.4M |
|
77
Johnson Controls International
JCI
$89.3B
| $51.5M | 0.12% |
1,188,128
-626,076
| -35% | -$26.2M |
|
|
AET
78
DELISTED
Aetna Inc
AET
| $51.4M | 0.12% |
338,762
-91,779
| -21% | -$13M |
|
79
Abbott
ABT
$185B
| $51.4M | 0.12% |
1,057,088
-179,911
| -15% | -$8.14M |
|
80
American International
AIG
$41.5B
| $50.6M | 0.12% |
808,996
-99,415
| -11% | -$6.18M |
|
81
Accenture
ACN
$102B
| $50.3M | 0.12% |
406,717
-20,407
| -5% | -$2.49M |
|
82
RBC Bearings
RBC
$17.9B
| $49.2M | 0.12% |
483,887
-47,508
| -9% | -$4.75M |
|
83
Philip Morris
PM
$296B
| $47.3M | 0.11% |
402,950
-93,821
| -19% | -$10.9M |
|
84
Halliburton
HAL
$26.7B
| $47.1M | 0.11% |
1,103,637
-373,525
| -25% | -$17.2M |
|
85
L3Harris
LHX
$51.6B
| $47M | 0.11% |
430,493
-66,152
| -13% | -$7.28M |
|
86
CBRE Group
CBRE
$42.3B
| $46.3M | 0.11% |
1,273,114
-236,094
| -16% | -$8.21M |
|
87
Texas Instruments
TXN
$247B
| $46.2M | 0.11% |
600,162
-59,029
| -9% | -$4.73M |
|
88
Eli Lilly
LLY
$1,000B
| $45.8M | 0.11% |
557,094
-99,789
| -15% | -$8.14M |
|
|
SEE
89
DELISTED
Sealed Air
SEE
| $45.1M | 0.11% |
1,008,019
+26,543
| +3% | +$1.17M |
|
90
M&T Bank
MTB
$35.9B
| $44.6M | 0.11% |
275,582
+15,995
| +6% | +$2.52M |
|
91
Norfolk Southern
NSC
$75.3B
| $44.1M | 0.1% |
362,373
-68,648
| -16% | -$8.07M |
|
92
MarketAxess Holdings
MKTX
$5.71B
| $42.8M | 0.1% |
213,007
-770
| -0.4% | -$147K |
|
|
AGN
93
DELISTED
Allergan plc
AGN
| $42.3M | 0.1% |
174,041
-33,243
| -16% | -$7.81M |
|
94
Merit Medical Systems
MMSI
$5.11B
| $41.7M | 0.1% |
1,092,404
+58,922
| +6% | +$1.97M |
|
95
Guidewire Software
GWRE
$13B
| $41.6M | 0.1% |
605,108
-55,375
| -8% | -$3.52M |
|
96
HealthEquity
HQY
$8.61B
| $41.5M | 0.1% |
832,497
-349
| -0% | -$16.3K |
|
97
Colgate-Palmolive
CL
$73.3B
| $40.8M | 0.1% |
550,268
-27,516
| -5% | -$2.04M |
|
98
Marathon Petroleum
MPC
$92.6B
| $40.7M | 0.1% |
777,417
-144,259
| -16% | -$7.45M |
|
|
PPLI
99
People Inc
PPLI
$3.17B
| $40.5M | 0.1% |
2,196,097
-425,553
| -16% | -$7.22M |
|
|
JBTM
100
JBT Marel
JBTM
$7.35B
| $40.3M | 0.09% |
410,875
-16,383
| -4% | -$1.45M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.